Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Anna Vlahiotis"'
Autor:
Yousef Zakharia, Despina Thomaidou, Benjamin Li, Gordon Siu, Rebecca Levin, Anna Vlahiotis, Dharanija Rao, Giovanni Zanotti
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundCombination axitinib plus pembrolizumab is a standard of care in the first-line treatment of patients with advanced clear cell renal cell carcinoma (RCC). This analysis describes the clinical characteristics, treatment management and outcom
Externí odkaz:
https://doaj.org/article/4e845bf4edd3426e9c4c7d59798c30bc
Autor:
Nicole Gidaya Bonine, Erika Banks, Amanda Harrington, Anna Vlahiotis, Laura Moore-Schiltz, Patrick Gillard
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background This study evaluated treatment patterns among women diagnosed with symptomatic uterine fibroids (UF) in the United States. Data were retrospectively extracted from the IBM Watson Health MarketScan® Commercial Claims and Encounter
Externí odkaz:
https://doaj.org/article/313fccf07d854e07baf5e0ff58d38203
Autor:
Santosh Gautam, Anna Vlahiotis, Maxine D. Fisher, Kendra DeBusk, Gregory A. Vidal, Sonia Pulgar
Publikováno v:
Future Oncology. 18:849-858
Aim: To describe real-world treatment patterns/outcomes among patients with HER2+ metastatic breast cancer (MBC). Materials & methods: Real-world treatments and overall survival (OS) were evaluated among adult women diagnosed with HER2+ MBC, with and
Autor:
Melissa Kirker, Anup Abraham, Anna Vlahiotis, Abhijeet Bhanegaonkar, Darrin Benjumea, Chai Kim, Haiyan Sun, Mairead Kearney, Sanjana Chandrasekar, Benjamin Li, Sheena Thakkar, Helen H Moon
Publikováno v:
Journal of Clinical Oncology. 41:468-468
468 Background: The standard-of-care first-line (1L) treatment for la/mUC is platinum-based chemotherapy (PBC) followed by avelumab 1L maintenance (1LM) in those who have not progressed following 1L PBC. This study aims to understand treatment patter
Autor:
Yousef Zakharia, Despina Thomaidou, Benjamin Li, Gordan Siu, Rebecca Levin, Anna Vlahiotis, Giovanni Zanotti
Publikováno v:
Journal of Clinical Oncology. 40:314-314
314 Background: The combination of axitinib plus pembrolizumab (AXI+PEM) is a standard of care in the first-line (1L) treatment of patients with advanced clear cell renal cell carcinoma (RCC). This analysis describes the demographic and clinical char
Autor:
Ashley L. Cole, Paul Juneau, Antoine C El Khoury, Anna Vlahiotis, Tony B. Amos, Janna Manjelievskaia
Publikováno v:
Journal of Medical Economics. 21:1221-1229
Much of the burden associated with schizophrenia is attributed to its early onset and chronic nature. Treatment with once monthly paliperidone palmitate (PP1M) is associated with lower healthcare utilization and better adherence as compared to oral a
Autor:
Marcus Shaker, Hemal Shah, Todd D. Green, Oth Tran, Timothy King, Joseph M. Chalil, Anna Vlahiotis, Matthew Greenhawt
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 124(4)
Peanut allergy (PA) affects approximately 1.6 million US children. The current standard of care is strict avoidance and prompt reaction treatment. Peanut allergy health care costs and health care resource utilization (HCRU) are poorly understood.To e
Autor:
Jason D. Buxbaum, A. Mark Fendrick, Swapnil Rajpathak, Michael E. Chernew, Yuexin Tang, Donna McMorrow, Anna Vlahiotis
Importance High-deductible health plans (HDHPs) are a common cost-savings option for employers but may lead to underuse of necessary treatments because beneficiaries bear the full cost of health care, including medications, until a deductible is met.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59062c5cb64c8315a63332017ce520f5
https://europepmc.org/articles/PMC6826641/
https://europepmc.org/articles/PMC6826641/
Publikováno v:
BMJ Open
ObjectivesHidradenitis suppurativa (HS) causes substantial morbidity and quality-of-life impairment. We examined demographic/clinical characteristics of patients with HS and treatment patterns, prevalence and healthcare resource utilisation/expenditu
Autor:
Amanda T. Harrington, Nicole G Bonine, Anna Vlahiotis, L. Moore-Schiltz, Erika Banks, Patrick Gillard
Publikováno v:
BMC Women's Health
BMC Women's Health, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Women's Health, Vol 20, Iss 1, Pp 1-13 (2020)
Background This study evaluated treatment patterns among women diagnosed with symptomatic uterine fibroids (UF) in the United States. Data were retrospectively extracted from the IBM Watson Health MarketScan® Commercial Claims and Encounters and Med